Delray Beach, Fla. – September 10, 2026 -- The global cold plasma market is projected to grow from USD 2.15 billion in 2026 to USD 3.03 billion by 2031, a 7.1% CAGR, according to MarketsandMarkets.
Mycronic's $87.5 million Surfx Technologies acquisition anchors 2025 deal activity
Mergers and acquisitions in the sector rose in 2025 versus 2024, driven by demand for atmospheric plasma capabilities in semiconductor and electronics manufacturing. Mycronic's acquisition of Surfx Technologies for approximately USD 87.5 million strengthened its surface cleaning and treatment offerings. The deal followed roughly USD 120 million in publicly disclosed investment and transaction value across the market during 2023–2026, with activity accelerating after 2024.
Niterra Ventures and ADTEC Healthcare fund medical plasma technologies
Niterra Ventures invested approximately USD 18 million in Neoplas Med in 2024 to support cold plasma wound-care technologies, while ADTEC Healthcare secured USD 12 million in funding in 2025 to advance medical cold plasma systems. Judges Scientific had earlier acquired Henniker Scientific for about USD 2.8 million in 2023, adding plasma surface-treatment and deposition technologies to its portfolio.
Polymer and plastics segment leads industry demand in 2025
The polymer and plastics industry is expected to hold the largest share of the cold plasma market in 2025, driven by demand for surface activation, adhesion, wettability and printability of plastic components and packaging. The medical industry segment is projected to post the highest CAGR at 8.5% through the forecast period, with wound healing identified as the fastest-growing application due to rising chronic wound cases and demand for non-invasive infection control.
Atmospheric cold plasma systems dominate with 63.2% share
The atmospheric cold plasma segment held a 63.2% market share in 2025, favored for enabling continuous, scalable processing without vacuum chambers. Surface treatment and activation applications commanded a 24.7% share in 2025 and are expected to remain the dominant application category.
Europe holds 33.9% share while Asia Pacific outpaces regional growth
Europe accounted for 33.9% of the global cold plasma market in 2025. Asia Pacific is forecast to register the highest regional growth rate, supported by expanding manufacturing activity, improving healthcare infrastructure and government initiatives across the region.
Vendors shift from standalone equipment to integrated plasma systems
Industry revenue is moving toward automated plasma systems, precision process control, integrated gas and power-management systems, and inline treatment solutions. Key players named in the report include Nordson Corporation, ADTEC Plasma Technology, Judges Scientific, PVA TePLa, Bodycote, Apyx Medical, Viromed Medical, Samco, Mycronic, Plasmatreat, P2i, Enercon Industries, Tantec, AcXys Plasma Technologies and Keylink.